Jeff Winograd, who's lived with depression for more than 25 years, says ketamine treatment saved his life. Jeff Winograd couldn’t get off his couch. He’d hit rock bottom with the depression he ...

A new study revealed that these programs may ... Study Finds New Link Between Food Choices, Depression and Alzheimer's Disease Feb. 5, 2025 — New research has shown that diet could influence the ...

Depression is a mental health condition that causes a chronic feeling of emptiness, sadness, or inability to feel pleasure that may appear to happen for no clear reason. Depression is the leading ...

One of the most common symptoms of depression in children is irritability. But children may also show symptoms more like those adults exhibit: sadness, lethargy, lack of interest in and withdrawal ...

Although depression most often arises in response to some kind of defeat, depression can seem to arise out of the blue, for no obvious reason. It may even arise when life appears to be going ...

Read on to learn more about the similarities and differences between Lexapro and Cymbalta and why a healthcare provider may recommend one of these medications over the other to treat depression.

You can get in touch with Alia by emailing [email protected]. Languages: English and Urdu Depression rates have reached record highs across the U.S. A Gallup poll from 2023 shows that 29 ...

Investing during a period of economic depression or recession can be daunting. However, choosing the right depression stocks can help you weather a period of uncertainty and protect your financial ...

Nearly 300 new genetic variants have been linked to depression, according to a new study that included a large sample of nearly 5 million people. The international team, led by researchers at the ...

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on an acquisition, study results ...

Methods We conducted an overview of systematic reviews to identify randomised controlled trials (RCTs) that compared the efficacy and adverse effects of non-pharmacological treatments of depression.

Background Major depressive disorder is estimated by the WHO to affect more than 300 million people globally, making depression the leading cause of disability worldwide. Antidepressants are commonly ...